Among them, anti-CD226 Abs remarkably suppressed the stimulatory function by inhibiting the production of TNF-α and IFN-γ by TIGIT+CD226+ CD4 T cells in both DM patients and HCs. This evidence concerns the gene CD4 and diabetes mellitus.